Veracyte | VCYT - Ebit



金融业
股票价格
USD
资产
USD 1.49B
现金及等价物
USD 299.52M
销售成本
USD 42.19M
流动资产
USD 574.78M
流动负债
USD 62.74M
债务
USD 39.33M
EBIT
USD 23.96M
EBITDA
USD 43.96M
员工
824
EPS每股收益
USD 0.54
股本和储备
USD 1.39B
销售毛利
USD 108.55M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.66B
净收入
USD 25.49M
营业费用
USD 126.36M
营业利润
USD 23.96M
普通股股本
USD 79.79M
PE价格收益
42.77
税前利润
USD 26.52M
销售收入
USD 150.32M
销售和管理费用
USD 55.71M
股票
USD 22.66M
贸易债权人
USD 8.02M
应收帐款人
USD 54.18M


Ebit 更改 日
Agenus USD 15.05M 656K 2026-03
Agilent USD 399M 46M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Illumina USD 260M 21M 2026-06
Intrexon USD -26.3M 2.91M 2024-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Laboratory Of America USD 456.7M 46.6M 2026-06
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 11.46B 1.91B 2026-06
Siemens EUR 3.19B 509M 2026-06
Sonic Healthcare AUD 423.94M 80.3M 2024-12
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Waters USD 10M 138M 2026-06